The present invention relates to therapeutic agents for renal diseases containing a colony-stimulating factor (CSF) as an active ingredient and renal tissue repairing/regenerating agents containing a colony-stimulating factor (CSF) as an active ingredient. The colony-stimulating factor (CSF) is preferably granulocyte colony-stimulating factor (G-CSF).